About Aarti Pharmalabs Limited
Data last updated: 20 December 2025
Aarti Pharmalabs Limited is a public limited company based in Vapi, Gujarat, India. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 22 November 2019, the company has been in operation for over 7 years.
Registered with ROC Ahmedabad under CIN L24100GJ2019PLC110964. Listed on BSE: 543748.
Capital: an authorised share capital of ₹50 Cr and a paid-up capital of ₹45.32 Cr. Formerly known as Aarti Organics Limited. It is led by directors including Vinay Gopal Nayak and Nehal Garewal.
Last AGM: 22 September 2025. Financial statements filed for year ended 31 March 2025. Office: Plot No. 22/C/1 & 22/C/2 1St Phase G.I.D.C. Vapi, Gujarat, India – 396195.
As per the financials filed for FY 2024, the company reported a revenue of ₹1,857.5 Cr, a decline of 5% compared to the previous year.
The company has a workforce of approximately 2,004 employees as per the latest available data. Its group structure includes 1 subsidiary and 1 joint venture.
The company is associated with 2 brands - Aarti Industries, Aarti Pharmalabs. As per MCA filings, the company has open charges of ₹400 Cr and satisfied charges of ₹75 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website aartipharmalabs.com.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media
-
Registered AddressPlot No. 22/C/1 & 22/C/2 1St Phase G.I.D.C. Vapi, Gujarat, India – 396195
-
IndustryPharma, API Manufacturers
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Aarti Pharmalabs Limited
Aarti Pharmalabs Limited has one previous CIN (Corporate Identification Number): U24100GJ2019PLC110964. The current CIN is L24100GJ2019PLC110964, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24100GJ2019PLC110964 | Current |
| U24100GJ2019PLC110964 | Previous |
Associated Brands with Aarti Pharmalabs Limited
Aarti Pharmalabs Limited operates two associated brands: Aarti Industries and Aarti Pharmalabs. These brands represent Aarti Pharmalabs Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Specialty chemicals, pharmaceuticals, and surfactants are manufactured. | aarti-industries.com | |
| Active pharmaceutical ingredients and intermediates are manufactured by Aarti Pharmalabs. | aartipharmalabs.com |
Business Activity of Aarti Pharmalabs Limited
Aarti Pharmalabs Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | ********* |
Auditor Details of Aarti Pharmalabs Limited
Aarti Pharmalabs Limited is audited by Gokhale & Sathe Chartered Accountants (ICAI peer reviewed, certificate valid till 2027-02-28) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| Gokhale & Sathe Chartered Accountants (ICAI peer reviewed, certificate valid till 2027-02-28) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Aarti Pharmalabs Limited
Aarti Pharmalabs Limited is currently managed by 13 directors, with 16 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Vinay Gopal Nayak
Also directs:
Aarti Pharmalabs Limited
|
Director | 17 Oct 2022 | 3 Years 8 Months | Current |
| Nehal Garewal | Director | 13 May 2024 | 2 Years 1 Months | Current |
|
Hetal Gogri Gala
Also directs:
Gogri Enterprises Limited Liability Partnership, Genesis Unichem Llp, Rose Peach Commercials Llp and 5 more
|
Managing Director | 07 Aug 2021 | 4 Years 11 Months | Current |
|
Rashesh Chandrakant Gogri
Also directs:
Gogri Enterprises Limited Liability Partnership, Genesis Unichem Llp, Dhanvallabh Ventures Llp and 5 more
|
Director | 07 Aug 2021 | 4 Years 11 Months | Current |
|
Bhavesh Rasiklal Vora
Also directs:
Aarti Pharmalabs Limited, Edelweiss Trusteeship Company Limited, Runwal Developers Limited and 1 more
|
Director | 17 Oct 2022 | 3 Years 8 Months | Current |
| Jeenal Kenil Savla | Director | 17 Oct 2022 | 3 Years 8 Months | Current |
Financials of Aarti Pharmalabs Limited FY 2026 filings available
Aarti Pharmalabs Limited reported revenue of ₹1,819.44 Cr (down 13.98% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Revenue from Operations | ₹1,819.44 Cr | ₹2,115.07 Cr | ₹1,852.61 Cr | ₹1,945.23 Cr |
| Other Income | ₹9.75 Cr | ₹10.12 Cr | ₹4.9 Cr | ₹2.32 Cr |
| Total Income | ₹1,829.19 Cr | ₹2,125.19 Cr | ₹1,857.5 Cr | ₹1,947.55 Cr |
| Cost of Materials Consumed | ₹830.06 Cr | ₹887.02 Cr | ₹858.45 Cr | ₹1,014.3 Cr |
| Purchases of Stock-in-Trade | ₹55.95 Cr | ₹176.63 Cr | ₹182.22 Cr | ₹280.82 Cr |
| Changes in Inventories | -₹51.18 Cr | ₹64.22 Cr | -₹19.95 Cr | -₹125.36 Cr |
| Employee Benefit Expense | ₹173.09 Cr | ₹161.96 Cr | ₹138.41 Cr | ₹129.69 Cr |
| Finance Costs | ₹46.9 Cr | ₹26.9 Cr | ₹17.21 Cr | ₹21.05 Cr |
| Depreciation & Amortisation | ₹104.34 Cr | ₹86.9 Cr | ₹73.24 Cr | ₹62.54 Cr |
| Other Expenses | ₹442.31 Cr | ₹360.87 Cr | ₹307.44 Cr | ₹303.74 Cr |
| Total Expenses | ₹1,601.47 Cr | ₹1,764.5 Cr | ₹1,557.01 Cr | ₹1,686.78 Cr |
| Profit Before Exceptional Items & Tax | ₹227.72 Cr | ₹360.69 Cr | ₹300.49 Cr | ₹260.77 Cr |
| Exceptional Items | -₹2.79 Cr | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹224.92 Cr | ₹360.69 Cr | ₹300.49 Cr | ₹260.77 Cr |
| Total Tax Expense | ₹58.21 Cr | ₹88.28 Cr | ₹83.59 Cr | ₹67.28 Cr |
| Net Profit | ₹174.71 Cr | ₹272.4 Cr | ₹216.9 Cr | ₹193.49 Cr |
| attributable to Owners | ₹172.71 Cr | - | ₹216.45 Cr | ₹193.49 Cr |
| attributable to NCI | ₹0 | - | ₹0 | ₹0 |
| Other Comprehensive Income | -₹6.24 Cr | -₹9.76 Cr | -₹45.12 Lakh | -₹3.45 Cr |
| Total Comprehensive Income | ₹168.47 Cr | ₹262.65 Cr | ₹216.45 Cr | ₹190.04 Cr |
| EBITDA (computed) | ₹378.96 Cr | ₹474.49 Cr | ₹390.94 Cr | ₹344.36 Cr |
| Basic EPS | ₹19.27 | ₹30.06 | ₹23.93 | ₹21.35 |
| Diluted EPS | ₹19.25 | ₹30.04 | ₹23.93 | ₹21.35 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹3,481.71 Cr | ₹2,906.41 Cr | ₹2,582.1 Cr | ₹2,230.93 Cr |
| Non-current Assets | ₹2,084.41 Cr | ₹1,584.24 Cr | ₹1,236.46 Cr | ₹1,075.17 Cr |
| Current Assets | ₹1,397.29 Cr | ₹1,322.17 Cr | ₹1,345.64 Cr | ₹1,155.76 Cr |
| Property, Plant & Equipment | ₹1,335.92 Cr | ₹1,104.12 Cr | ₹1,014.69 Cr | ₹922.74 Cr |
| Inventories | ₹640.31 Cr | ₹587.58 Cr | ₹642.86 Cr | ₹602.04 Cr |
| Trade Receivables | ₹583.32 Cr | ₹575.4 Cr | ₹519.34 Cr | ₹440.05 Cr |
| Cash & Equivalents | ₹8.53 Cr | ₹6.73 Cr | ₹23.63 Cr | ₹24.93 Cr |
| Equity (Net Worth) | ₹2,124.6 Cr | ₹1,989.91 Cr | ₹1,757.04 Cr | ₹1,558.48 Cr |
| Equity Share Capital | ₹45.33 Cr | ₹45.32 Cr | ₹45.31 Cr | ₹45.31 Cr |
| Borrowings (Non-current) | ₹185.81 Cr | ₹103.56 Cr | ₹3.88 Lakh | ₹18 Lakh |
| Borrowings (Current) | ₹499.82 Cr | ₹292.8 Cr | ₹264.06 Cr | ₹213.78 Cr |
| Total Debt (computed) | ₹685.63 Cr | ₹396.35 Cr | ₹264.1 Cr | ₹213.96 Cr |
| Current Liabilities | ₹937.57 Cr | ₹657.05 Cr | ₹694.38 Cr | ₹591.58 Cr |
| Total Liabilities | ₹1,357.1 Cr | ₹916.5 Cr | ₹825.06 Cr | ₹672.45 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Operating Cash Flow | ₹261.93 Cr | ₹331.56 Cr | ₹216.36 Cr | ₹263 Cr |
| Investing Cash Flow | -₹430.72 Cr | -₹413.9 Cr | -₹214.57 Cr | -₹157.8 Cr |
| Financing Cash Flow | ₹170.58 Cr | ₹65.44 Cr | ₹9.72 Cr | -₹163.47 Cr |
| Capital Expenditure | ₹409.37 Cr | ₹402.04 Cr | ₹155.6 Cr | ₹119.65 Cr |
| Free Cash Flow (computed) | -₹147.44 Cr | -₹70.48 Cr | ₹60.75 Cr | ₹143.35 Cr |
| Dividends Paid | ₹36.26 Cr | ₹31.72 Cr | ₹18.13 Cr | ₹0 |
| Net Change in Cash | ₹1.8 Cr | -₹16.9 Cr | ₹11.51 Cr | -₹58.27 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹582.64 Cr | ₹432.27 Cr | ₹418.33 Cr | ₹386.19 Cr | ₹563.78 Cr | ₹537.78 Cr | ₹458.03 Cr | ₹555.49 Cr | ₹505.77 Cr | ₹448.69 Cr | ₹439.8 Cr | ₹458.36 Cr |
| Other Income | ₹8.05 Cr | -₹37.12 Lakh | ₹5.03 Lakh | ₹1.6 Cr | -₹1.61 Cr | ₹5.03 Cr | ₹4.48 Cr | ₹2.22 Cr | ₹2.03 Cr | ₹1.39 Cr | ₹98 Lakh | ₹48 Lakh |
| Total Income | ₹590.7 Cr | ₹431.9 Cr | ₹418.39 Cr | ₹387.79 Cr | ₹562.17 Cr | ₹542.81 Cr | ₹462.51 Cr | ₹557.71 Cr | ₹507.8 Cr | ₹450.08 Cr | ₹440.78 Cr | ₹458.84 Cr |
| Cost of Materials Consumed | ₹225.76 Cr | ₹209.42 Cr | ₹203.46 Cr | ₹191.42 Cr | ₹185.45 Cr | ₹261.19 Cr | ₹220.58 Cr | ₹219.81 Cr | ₹201.52 Cr | ₹214.96 Cr | ₹221.89 Cr | ₹220.07 Cr |
| Purchases of Stock-in-Trade | ₹8.73 Cr | ₹2.14 Cr | ₹23.26 Cr | ₹21.82 Cr | -₹16.27 Cr | ₹7.87 Cr | ₹98.1 Cr | ₹86.94 Cr | ₹59.91 Cr | ₹38.46 Cr | ₹35.2 Cr | ₹48.65 Cr |
| Changes in Inventories | ₹48.53 Cr | -₹38.9 Cr | -₹16.95 Cr | -₹43.84 Cr | ₹109.57 Cr | ₹6.25 Cr | -₹83.1 Cr | ₹31.5 Cr | -₹8.31 Cr | -₹8.99 Cr | -₹4.84 Cr | ₹2.2 Cr |
| Employee Benefit Expense | ₹45.05 Cr | ₹43.38 Cr | ₹43.41 Cr | ₹41.26 Cr | ₹43.37 Cr | ₹41.63 Cr | ₹37.73 Cr | ₹39.23 Cr | ₹37.4 Cr | ₹36.16 Cr | ₹31.6 Cr | ₹33.25 Cr |
| Finance Costs | ₹16.86 Cr | ₹12.58 Cr | ₹10.67 Cr | ₹6.79 Cr | ₹6.58 Cr | ₹9.97 Cr | ₹5.51 Cr | ₹4.83 Cr | ₹4.68 Cr | ₹4.48 Cr | ₹3.89 Cr | ₹4.17 Cr |
| Depreciation & Amortisation | ₹28.16 Cr | ₹28.62 Cr | ₹24.77 Cr | ₹22.79 Cr | ₹22.82 Cr | ₹23.04 Cr | ₹20.88 Cr | ₹20.17 Cr | ₹19.12 Cr | ₹18.77 Cr | ₹18.14 Cr | ₹17.2 Cr |
| Other Expenses | ₹141.44 Cr | ₹113.93 Cr | ₹90.43 Cr | ₹80.29 Cr | ₹96.03 Cr | ₹92.23 Cr | ₹91.05 Cr | ₹81.56 Cr | ₹97.73 Cr | ₹72.43 Cr | ₹67.95 Cr | ₹69.32 Cr |
| Total Expenses | ₹514.53 Cr | ₹371.16 Cr | ₹379.05 Cr | ₹320.54 Cr | ₹447.55 Cr | ₹442.18 Cr | ₹390.74 Cr | ₹484.03 Cr | ₹412.05 Cr | ₹376.26 Cr | ₹373.83 Cr | ₹394.86 Cr |
| Profit Before Exceptional Items & Tax | ₹76.17 Cr | ₹60.74 Cr | ₹39.33 Cr | ₹67.25 Cr | ₹114.62 Cr | ₹100.63 Cr | ₹71.77 Cr | ₹73.68 Cr | ₹95.75 Cr | ₹73.82 Cr | ₹66.95 Cr | ₹63.98 Cr |
| Exceptional Items | ₹0 | -₹2.79 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹76.17 Cr | ₹57.95 Cr | ₹39.33 Cr | ₹67.25 Cr | ₹114.62 Cr | ₹100.63 Cr | ₹71.77 Cr | ₹73.68 Cr | ₹95.75 Cr | ₹73.82 Cr | ₹66.95 Cr | ₹63.98 Cr |
| Total Tax Expense | ₹20.55 Cr | ₹14.91 Cr | ₹10.77 Cr | ₹15.95 Cr | ₹26.28 Cr | ₹26.64 Cr | ₹17.15 Cr | ₹18.22 Cr | ₹30.5 Cr | ₹21.06 Cr | ₹15.15 Cr | ₹16.89 Cr |
| Net Profit | ₹61.12 Cr | ₹47.96 Cr | ₹27.92 Cr | ₹49.5 Cr | ₹88.34 Cr | ₹73.99 Cr | ₹54.62 Cr | ₹55.45 Cr | ₹65.25 Cr | ₹52.76 Cr | ₹51.8 Cr | ₹47.09 Cr |
| attributable to Owners | ₹61.12 Cr | ₹46.39 Cr | ₹28.57 Cr | - | - | ₹73.99 Cr | ₹54.62 Cr | ₹55.45 Cr | ₹64.36 Cr | ₹52.76 Cr | ₹51.8 Cr | ₹50.97 Cr |
| attributable to NCI | ₹0 | ₹0 | ₹0 | - | - | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Other Comprehensive Income | -₹4.87 Cr | -₹1.56 Cr | -₹77.19 Lakh | ₹96.62 Lakh | -₹4.76 Cr | -₹2.71 Cr | -₹2.77 Cr | ₹48.34 Lakh | -₹89.13 Lakh | ₹29.28 Lakh | -₹3.73 Cr | ₹3.88 Cr |
| Total Comprehensive Income | ₹56.25 Cr | ₹46.39 Cr | ₹27.15 Cr | ₹50.47 Cr | ₹83.58 Cr | ₹71.28 Cr | ₹51.85 Cr | ₹55.94 Cr | ₹64.36 Cr | ₹53.06 Cr | ₹48.07 Cr | ₹50.97 Cr |
| EBITDA (computed) | ₹121.18 Cr | ₹101.94 Cr | ₹74.77 Cr | ₹96.84 Cr | ₹144.02 Cr | ₹133.64 Cr | ₹98.16 Cr | ₹98.68 Cr | ₹119.55 Cr | ₹97.07 Cr | ₹88.98 Cr | ₹85.35 Cr |
| Basic EPS | ₹6.74 | ₹5.29 | ₹3.08 | ₹5.46 | ₹9.75 | ₹8.16 | ₹6.03 | ₹6.12 | ₹7.20 | ₹5.82 | ₹5.72 | ₹5.20 |
| Diluted EPS | ₹6.74 | ₹5.29 | ₹3.08 | ₹5.46 | ₹9.74 | ₹8.16 | ₹6.02 | ₹6.12 | ₹7.20 | ₹5.82 | ₹5.72 | ₹5.20 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Revenue from Operations | ₹1,797.55 Cr | ₹1,771.35 Cr | ₹1,502.13 Cr | ₹1,511.25 Cr |
| Other Income | ₹15.32 Cr | ₹14.49 Cr | ₹11.01 Cr | ₹1.28 Cr |
| Total Income | ₹1,812.87 Cr | ₹1,785.84 Cr | ₹1,513.14 Cr | ₹1,512.53 Cr |
| Cost of Materials Consumed | ₹834.53 Cr | ₹803.98 Cr | ₹761.57 Cr | ₹899.45 Cr |
| Purchases of Stock-in-Trade | ₹49.19 Cr | ₹27.43 Cr | ₹13.76 Cr | ₹9.7 Cr |
| Changes in Inventories | -₹62.58 Cr | ₹47.85 Cr | -₹23.36 Cr | -₹91.22 Cr |
| Employee Benefit Expense | ₹170.48 Cr | ₹152.88 Cr | ₹130.33 Cr | ₹122.16 Cr |
| Finance Costs | ₹46.9 Cr | ₹25.63 Cr | ₹16.63 Cr | ₹20.48 Cr |
| Depreciation & Amortisation | ₹104.3 Cr | ₹79.06 Cr | ₹66.01 Cr | ₹55.77 Cr |
| Other Expenses | ₹433.02 Cr | ₹312.66 Cr | ₹273.67 Cr | ₹262.83 Cr |
| Total Expenses | ₹1,575.84 Cr | ₹1,449.5 Cr | ₹1,238.62 Cr | ₹1,279.17 Cr |
| Profit Before Exceptional Items & Tax | ₹237.03 Cr | ₹336.34 Cr | ₹274.52 Cr | ₹233.36 Cr |
| Exceptional Items | -₹2.79 Cr | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹234.24 Cr | ₹336.34 Cr | ₹274.52 Cr | ₹233.36 Cr |
| Total Tax Expense | ₹58.04 Cr | ₹78.99 Cr | ₹73.87 Cr | ₹61.63 Cr |
| Net Profit | ₹176.2 Cr | ₹257.35 Cr | ₹200.65 Cr | ₹171.73 Cr |
| Other Comprehensive Income | -₹3.95 Cr | -₹5.16 Cr | ₹13.31 Lakh | -₹70 Lakh |
| Total Comprehensive Income | ₹172.25 Cr | ₹252.19 Cr | ₹200.78 Cr | ₹171.03 Cr |
| EBITDA (computed) | ₹388.23 Cr | ₹441.03 Cr | ₹357.17 Cr | ₹309.61 Cr |
| Basic EPS | ₹19.44 | ₹28.39 | ₹22.14 | ₹18.95 |
| Diluted EPS | ₹19.42 | ₹28.38 | ₹22.14 | ₹18.85 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹3,327.76 Cr | ₹2,723.61 Cr | ₹2,296.91 Cr | ₹1,963.27 Cr |
| Non-current Assets | ₹1,934.33 Cr | ₹1,510.81 Cr | ₹1,162.85 Cr | ₹1,004.3 Cr |
| Current Assets | ₹1,393.43 Cr | ₹1,212.8 Cr | ₹1,134.06 Cr | ₹958.97 Cr |
| Property, Plant & Equipment | ₹1,335.92 Cr | ₹1,028.77 Cr | ₹936.47 Cr | ₹847.08 Cr |
| Inventories | ₹636.21 Cr | ₹544.22 Cr | ₹582.15 Cr | ₹537.68 Cr |
| Trade Receivables | ₹586.55 Cr | ₹552.59 Cr | ₹448.82 Cr | ₹361.61 Cr |
| Cash & Equivalents | ₹5.54 Cr | ₹2.84 Cr | ₹4 Cr | ₹13.11 Cr |
| Equity (Net Worth) | ₹1,982.35 Cr | ₹1,843.87 Cr | ₹1,621.46 Cr | ₹1,438.58 Cr |
| Equity Share Capital | ₹45.33 Cr | ₹45.32 Cr | ₹45.31 Cr | ₹45.31 Cr |
| Borrowings (Non-current) | ₹185.81 Cr | ₹103.56 Cr | ₹0 | ₹0 |
| Borrowings (Current) | ₹499.82 Cr | ₹291.3 Cr | ₹250.8 Cr | ₹206.71 Cr |
| Total Debt (computed) | ₹685.63 Cr | ₹394.86 Cr | ₹250.8 Cr | ₹206.71 Cr |
| Current Liabilities | ₹925.88 Cr | ₹622.33 Cr | ₹555.58 Cr | ₹455.31 Cr |
| Total Liabilities | ₹1,345.41 Cr | ₹879.74 Cr | ₹675.45 Cr | ₹524.69 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Operating Cash Flow | ₹256.13 Cr | ₹340.01 Cr | ₹183.7 Cr | ₹228.69 Cr |
| Investing Cash Flow | -₹424.02 Cr | -₹419.8 Cr | -₹184.4 Cr | -₹115.56 Cr |
| Financing Cash Flow | ₹170.58 Cr | ₹78.63 Cr | ₹4.4 Cr | -₹156.52 Cr |
| Capital Expenditure | ₹409.37 Cr | ₹391.48 Cr | ₹145.96 Cr | ₹0 |
| Free Cash Flow (computed) | -₹153.23 Cr | -₹51.47 Cr | ₹37.74 Cr | ₹228.69 Cr |
| Dividends Paid | ₹36.26 Cr | ₹31.72 Cr | ₹18.13 Cr | ₹18.12 Cr |
| Net Change in Cash | ₹2.7 Cr | -₹1.16 Cr | ₹3.7 Cr | -₹43.39 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹579.7 Cr | ₹425.25 Cr | ₹417.29 Cr | ₹375.31 Cr | ₹529.62 Cr | ₹470.95 Cr | ₹377.29 Cr | ₹393.49 Cr | ₹414.82 Cr | ₹373.03 Cr | ₹356.14 Cr | ₹358.14 Cr |
| Other Income | ₹10.53 Cr | -₹37.12 Lakh | ₹3.15 Cr | ₹1.6 Cr | -₹2.51 Cr | ₹11.94 Cr | ₹2.95 Cr | ₹2.11 Cr | ₹5.69 Cr | ₹19.94 Lakh | ₹0 | ₹4.86 Cr |
| Total Income | ₹590.23 Cr | ₹424.88 Cr | ₹420.44 Cr | ₹376.91 Cr | ₹527.12 Cr | ₹482.88 Cr | ₹380.24 Cr | ₹395.6 Cr | ₹420.5 Cr | ₹373.23 Cr | ₹356.14 Cr | ₹363 Cr |
| Cost of Materials Consumed | ₹227.38 Cr | ₹209.85 Cr | ₹204.45 Cr | ₹192.85 Cr | ₹173.29 Cr | ₹242.91 Cr | ₹196.38 Cr | ₹191.41 Cr | ₹179.69 Cr | ₹191.11 Cr | ₹196.88 Cr | ₹193.64 Cr |
| Purchases of Stock-in-Trade | ₹7.07 Cr | ₹1.86 Cr | ₹20.41 Cr | ₹19.85 Cr | ₹3.34 Cr | ₹2.44 Cr | ₹20 Cr | ₹1.65 Cr | ₹0 | ₹0 | ₹0 | ₹14.01 Cr |
| Changes in Inventories | ₹45.5 Cr | -₹40.28 Cr | -₹14.86 Cr | -₹52.95 Cr | ₹83.47 Cr | -₹9.15 Cr | -₹36.56 Cr | ₹10.09 Cr | ₹7.36 Cr | -₹5.32 Cr | -₹6.11 Cr | -₹19.29 Cr |
| Employee Benefit Expense | ₹43.73 Cr | ₹42.62 Cr | ₹43.12 Cr | ₹41.01 Cr | ₹41.38 Cr | ₹39.02 Cr | ₹35.47 Cr | ₹37.01 Cr | ₹34.67 Cr | ₹34.29 Cr | ₹29.84 Cr | ₹31.53 Cr |
| Finance Costs | ₹16.86 Cr | ₹12.58 Cr | ₹10.66 Cr | ₹6.79 Cr | ₹6.29 Cr | ₹9.7 Cr | ₹5.39 Cr | ₹4.25 Cr | ₹4.42 Cr | ₹4.1 Cr | ₹3.82 Cr | ₹4.03 Cr |
| Depreciation & Amortisation | ₹28.16 Cr | ₹28.62 Cr | ₹24.77 Cr | ₹22.76 Cr | ₹20.83 Cr | ₹21.04 Cr | ₹18.89 Cr | ₹18.29 Cr | ₹17.32 Cr | ₹16.94 Cr | ₹16.32 Cr | ₹15.44 Cr |
| Other Expenses | ₹138.94 Cr | ₹108.25 Cr | ₹90.19 Cr | ₹79.41 Cr | ₹85.02 Cr | ₹80.75 Cr | ₹77.23 Cr | ₹69.67 Cr | ₹85.75 Cr | ₹64.68 Cr | ₹61.73 Cr | ₹61.51 Cr |
| Total Expenses | ₹507.65 Cr | ₹363.51 Cr | ₹378.74 Cr | ₹309.73 Cr | ₹413.62 Cr | ₹386.7 Cr | ₹316.81 Cr | ₹332.37 Cr | ₹329.22 Cr | ₹305.79 Cr | ₹302.48 Cr | ₹300.87 Cr |
| Profit Before Exceptional Items & Tax | ₹82.59 Cr | ₹61.38 Cr | ₹41.7 Cr | ₹67.17 Cr | ₹113.5 Cr | ₹96.18 Cr | ₹63.43 Cr | ₹63.23 Cr | ₹91.28 Cr | ₹67.44 Cr | ₹53.66 Cr | ₹62.13 Cr |
| Exceptional Items | ₹0 | -₹2.79 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹82.59 Cr | ₹58.58 Cr | ₹41.7 Cr | ₹67.17 Cr | ₹113.5 Cr | ₹96.18 Cr | ₹63.43 Cr | ₹63.23 Cr | ₹91.28 Cr | ₹67.44 Cr | ₹53.66 Cr | ₹62.13 Cr |
| Total Tax Expense | ₹20.55 Cr | ₹14.74 Cr | ₹10.77 Cr | ₹15.95 Cr | ₹24.66 Cr | ₹22.66 Cr | ₹15.6 Cr | ₹16.08 Cr | ₹28.26 Cr | ₹19.25 Cr | ₹11.86 Cr | ₹14.5 Cr |
| Net Profit | ₹62.03 Cr | ₹43.84 Cr | ₹30.93 Cr | ₹51.22 Cr | ₹88.85 Cr | ₹73.52 Cr | ₹47.84 Cr | ₹47.14 Cr | ₹63.02 Cr | ₹48.19 Cr | ₹41.18 Cr | ₹47.63 Cr |
| Other Comprehensive Income | -₹3.52 Cr | ₹63.01 Lakh | -₹2.12 Cr | ₹1.05 Cr | -₹1.88 Cr | -₹1.87 Cr | -₹1.17 Cr | -₹23.16 Lakh | -₹1.11 Cr | ₹70.39 Lakh | ₹0 | ₹1.17 Cr |
| Total Comprehensive Income | ₹58.51 Cr | ₹44.47 Cr | ₹28.81 Cr | ₹52.27 Cr | ₹86.97 Cr | ₹71.65 Cr | ₹46.66 Cr | ₹46.91 Cr | ₹61.91 Cr | ₹48.89 Cr | ₹41.18 Cr | ₹48.8 Cr |
| EBITDA (computed) | ₹127.6 Cr | ₹102.57 Cr | ₹77.13 Cr | ₹96.73 Cr | ₹140.62 Cr | ₹126.93 Cr | ₹87.72 Cr | ₹85.77 Cr | ₹113.03 Cr | ₹88.47 Cr | ₹73.8 Cr | ₹81.6 Cr |
| Basic EPS | ₹6.84 | ₹4.84 | ₹3.41 | ₹5.65 | ₹9.80 | ₹8.11 | ₹5.28 | ₹5.20 | ₹6.95 | ₹5.32 | ₹4.61 | ₹5.26 |
| Diluted EPS | ₹6.84 | ₹4.83 | ₹3.41 | ₹5.65 | ₹9.80 | ₹8.11 | ₹5.27 | ₹5.20 | ₹6.95 | ₹5.32 | ₹4.61 | ₹5.26 |
Shareholding Pattern of Aarti Pharmalabs Limited
As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 43.08%, foreign institutional investors hold 8.39%, domestic institutional investors hold 7.41%, retail and other public shareholders hold 41.11% of Aarti Pharmalabs Limited. The company had 179,373 shareholders on record.
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Promoters | 43.08% | 43.10% | 42.88% | 43.72% | 44.29% | 44.66% |
| Public | 56.92% | 56.90% | 57.12% | 56.28% | 55.71% | 55.34% |
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | |
|---|---|---|---|---|
| Promoters | 43.08% | 44.29% | 46.46% | 45.98% |
| Public | 56.92% | 55.71% | 53.54% | 54.02% |
| Promoter change (YoY, %pts) | -1.21 | -2.17 | +0.48 | - |
Board & Governance of Aarti Pharmalabs Limited
As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Aarti Pharmalabs Limited has 12 directors - 6 independent and 2 executive. The board is chaired by Rashesh Chandrakant Gogri.
| Director | Position | On board since | Listed boards |
|---|---|---|---|
| Rashesh Chandrakant Gogri | Non-Executive - Non Independent Director · Chairperson | 2021-08-07 | 3 |
| Hetal Gogri Gala | Executive Director · MD | 2021-08-07 | 2 |
| Narendra Jagannath Salvi | Executive Director · MD | 2021-08-07 | 2 |
| Rajendra Vallabhaji Gogri | Non-Executive - Non Independent Director | 2021-08-07 | 4 |
| Parimal Hasmukhlal Desai | Non-Executive - Non Independent Director | 2022-10-17 | 3 |
| Vinay Gopal Nayak | Non-Executive - Independent Director | 2022-10-17 | 1 |
| Bhavesh Rasiklal Vora | Non-Executive - Independent Director | 2022-10-17 | 1 |
| Jeenal Kenil Savla | Non-Executive - Independent Director | 2022-10-17 | 1 |
| Rupal Anand Vora | Non-Executive - Independent Director | 2022-10-17 | 6 |
| Vilas Gajanan Gaikar | Non-Executive - Independent Director | 2022-10-17 | 1 |
| Pradeep Hari Thakur | Non-Executive - Independent Director | 2024-05-13 | 3 |
| Nehal Garewal | Non-Executive - Non Independent Director | 2024-05-13 | 1 |
| Committee | Members |
|---|---|
| Audit Committee | Bhavesh Rasiklal Vora (Chairperson), Vinay Gopal Nayak, Vilas Gajanan Gaikar, Jeenal Kenil Savla, Hetal Gogri Gala, Narendra Jagannath Salvi |
| Nomination and remuneration committee | Jeenal Kenil Savla (Chairperson), Vinay Gopal Nayak, Rashesh Chandrakant Gogri |
| Stakeholders Relationship Committee | Rajendra Vallabhaji Gogri (Chairperson), Narendra Jagannath Salvi, Bhavesh Rasiklal Vora, Rupal Anand Vora |
| Risk Management Committee | Rashesh Chandrakant Gogri (Chairperson), Hetal Gogri Gala, Narendra Jagannath Salvi, Rajendra Vallabhaji Gogri, Parimal Hasmukhlal Desai, Vinay Gopal Nayak |
| Corporate Social Responsibility Committee | Hetal Gogri Gala (Chairperson), Rajendra Vallabhaji Gogri, Jeenal Kenil Savla, Vilas Gajanan Gaikar |
| Finance and Investment Committee | Rashesh Chandrakant Gogri (Chairperson), Hetal Gogri Gala, Narendra Jagannath Salvi, Rajendra Vallabhaji Gogri, Parimal Hasmukhlal Desai |
Group Structure of Aarti Pharmalabs Limited
Aarti Pharmalabs Limited has 1 subsidiary company and 1 joint venture. This group structure data is as of FY 2024. The corporate group structure reflects Aarti Pharmalabs Limited's business expansion strategy and organizational complexity.
| Company Name | CIN | Shares Held |
|---|---|---|
| Aarti Pharmachem Limited | U24290MH2019PLC333628 | - |
Showing major subsidiaries. Total: 1.
Charges & Borrowings of Aarti Pharmalabs Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Mar 2025 | Idbi Bank Limited | ₹75 Cr | Open |
| 08 Sep 2024 | Citi Bank N.A. | ₹70 Cr | Open |
| 08 Sep 2024 | Citi Bank N.A. | ₹30 Cr | Open |
| 09 Feb 2023 | Axis Bank Limited | ₹75 Cr | Open |
| 11 Jan 2023 | Standard Chartered Bank | ₹75 Cr | Open |
Total charge records: 7 View all charges
Employees and EPFO Compliance at Aarti Pharmalabs Limited
Aarti Pharmalabs Limited has a workforce of 2,004 employees as of Apr 06, 2024.
Employee Count & EPFO Data of Aarti Pharmalabs Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Aarti Pharmalabs Limited
GSTIN & GST Filing Data of Aarti Pharmalabs Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Aarti Pharmalabs Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Aarti Pharmalabs Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Aarti Pharmalabs Limited
MSME Payment Delays by Aarti Pharmalabs Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Aarti Pharmalabs Limited
Subsidiaries & Group Companies of Aarti Pharmalabs Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Aarti Pharmalabs Limited with ownership details.
MCA Filings & Documents of Aarti Pharmalabs Limited
MCA Filings & Documents of Aarti Pharmalabs Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Aarti Pharmalabs Limited
Recent News on Aarti Pharmalabs Limited
Frequently Asked Questions about Aarti Pharmalabs Limited
Aarti Pharmalabs Limited is an active public limited company in the pharma sector based in Vapi, Gujarat, India. It was incorporated on 22 November 2019 (7+ years old) and is registered under CIN L24100GJ2019PLC110964. Listed on BSE: 543748. The company has 2,004 employees.
Aarti Pharmalabs Limited reported revenue of ₹1,857.5 Cr for FY 2024 (down 5.00% YoY).
The current directors of Aarti Pharmalabs Limited are:
The primary industry of Aarti Pharmalabs Limited is pharma. The company specifically operates in api manufacturers. The company is currently active in this sector.
Yes. Aarti Pharmalabs Limited is listed on BSE with code 543748.
Aarti Pharmalabs Limited can be reached at the registered office: Plot No. 22C1 & 22C2 1St Phase G.I.D.C. Vapi, Gujarat, India – 396195, or through the website aartipharmalabs.com.